SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
LYCA

Lycia Therapeutics, Inc. (NASDAQ:LYCA)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
27.73+2.68 (+10.70%)
 
Market cap
$1.44B
Insider Score
Listed since
Oct 23, 2026
Insider Score
––Not scored
LYCA Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

LYCA Income Statement

No quarterly statements available for LYCA.

Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
Lycia Therapeutics, Inc. (LYCA) Financials: Revenue, Earnings & Balance Sheet | InsiderBuying.com